STUDIO CITY, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN) has announced its presence at the XIII World Congress on Cardiac Pacing and Electrophysiology to be held December 2-6, 2007 in Rome, Italy. At the Congress, Dr. Muricio Arruda, who has been testing Signalife's wireless Fidelity 400 Intracardiac Monitor at the Electrophysiology Laboratories of the Cleveland Clinic Heart Center, will present a prototoype of the Fidelity 400 Intracardiac Monitor to selected participants. The Signalife Fidelity 400 Intracardiac Monitor applies Signalife's award-winning proprietary physiological signal acquisition and amplification technology to read intracardiac signals procured from intracardiac catheter products. An intracardiac catheter is a flexible tube that is inserted through a vein in the leg and fed into the heart. The catheter is equipped with electrodes which allows the signal to be recorded within the heart, and the catheter data is transmitted to a monitor, which allows the physician to evaluate cardiac function, including arrhythmia, or irregular heartbeat. These readings are beneficial in that they measure signals directly from the heart, as opposed to signals read from the surface of the body as is typical in the ordinary application of heart monitors.
The mission of the World Congress of Cardiac Pacing and
Electrophysiology is to provide an education forum, underlining
evidence-based clinical practices in the field of arrhythmology for
clinical cardiologists and electrophysiologists. The Congress will also
highlight the latest and most advanced topics in invasive electrophysiology
and cardiac pacing, giving leading electrophysiologists the opportunity to
demonstrate and discuss new dia
|SOURCE Signalife, Inc.|
Copyright©2007 PR Newswire.
All rights reserved